Amazon Web Services boosts machine learning to treat depression

Healthcare IT News: Pharmaceutical company Takeda and research and development data science institute ConvergeHEALTH by Deloitte have partnered to study patient datasets to better understand the etiology, progression and most effective therapies for difficult diseases.

Using insurance claims information including diagnoses, medical procedures and prescriptions, they ran linear and non-linear models on disease datasets like treatment-resistant depression. The goal was to identify data factors with the highest impact on predicting patient outcomes.

Read article